Filing metadata

Accession number
0001213900-22-075960
Form type
Form 3
Filer
InMed Pharmaceuticals Inc.
CIK
CIK 1728328
Filed
Nov 29, 2022
Reporting period
Nov 16, 2022
Description
Initial ownership

Explore SEC Filings Hub